The global treatment market for melanoma will expand more than fourfold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by 2023, representing a robust Compound Annual Growth Rate (CAGR) of 15.5%.
Reportstack’s latest report "PharmaPoint: Melanoma-Global Drug Forecast and Market Analysis to 2023" states that this...
More...




